郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价A Novel Selective Inverse Agonist of the CB2 Receptor as a Radiolabeled Tool Compound for Kinetic Binding Studies.

期刊:Molecular pharmacology发表年份:2017作者:Andrea Martella; Huub Sijben; Arne C Rufer; Uwe Grether; Juergen Fingerle; Christoph Ullmer; Thomas Hartung; Adriaan P IJzerman; Mario van der Stelt; Laura H Heitman

药效评价A common mechanism for CFTR potentiators.

期刊:The Journal of general physiology发表年份:2017作者:Han-I Yeh; Yoshiro Sohma; Katja Conrath; Tzyh-Chang Hwang

药效评价Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile.

期刊:Bioorganic & medicinal chemistry发表年份:2017作者:Vittorio Canale; Anna Partyka; Rafał Kurczab; Martyna Krawczyk; Tomasz Kos; Grzegorz Satała; Bartłomiej Kubica; Magdalena Jastrzębska-Więsek; Anna Wesołowska; Andrzej J Bojarski; Piotr Popik; Paweł Zajdel

药效评价Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3.

期刊:Cellular and molecular life sciences : CMLS发表年份:2017作者:Trinidad Montero-Melendez; Rachel A E Forfar; Jennifer M Cook; Jeffrey C Jerman; Debra L Taylor; Mauro Perretti